BACKGROUND: Data comparing type-specific herpes simplex virus type 2 (HSV-2) seroprevalence and risk factors between comparable populations are largely unavailable, particularly from less-developed countries. GOAL: To examine the seroprevalence of HSV-2 infection and the risk factors for this infection among women in São Paulo, Brazil, and Manila, the Philippines. STUDY DESIGN: Altogether, 552 middle-aged women participating as control subjects in two cervical cancer studies were screened for type-specific HSV-2 antibodies. RESULTS: Herpes simplex virus type 2 seroprevalence was higher in Brazil (42%) than in the Philippines (9.2%). The mean ages of Brazilian (n = 181) and Filipino (n = 371) women were 52.4 and 46.6 years, respectively. Brazilian participants had more lifetime sexual partners, less education, and more often a husband with other sexual partners than Filipino women. Herpes simplex virus type 2 was independently associated with younger age at first intercourse in both countries. More than one lifetime sexual partner, a husband with other sexual partners, urban/semi-urban residence, and no history of condom use were HSV-2 risk factors in Brazil, but not in the Philippines, where long-term hormonal contraceptive use was associated with increased risk. CONCLUSIONS: The higher HSV-2 seroprevalence in Brazil than in the Philippines may be explained largely by differences in the sexual behavior of women and their husbands. Herpes simplex virus type 2 seroprevalence data may be used as a marker of past sexual behavior for the direct comparison of different population groups.
BACKGROUND: Data comparing type-specific herpes simplex virus type 2 (HSV-2) seroprevalence and risk factors between comparable populations are largely unavailable, particularly from less-developed countries. GOAL: To examine the seroprevalence of HSV-2 infection and the risk factors for this infection among women in São Paulo, Brazil, and Manila, the Philippines. STUDY DESIGN: Altogether, 552 middle-aged women participating as control subjects in two cervical cancer studies were screened for type-specific HSV-2 antibodies. RESULTS:Herpes simplex virus type 2 seroprevalence was higher in Brazil (42%) than in the Philippines (9.2%). The mean ages of Brazilian (n = 181) and Filipino (n = 371) women were 52.4 and 46.6 years, respectively. Brazilian participants had more lifetime sexual partners, less education, and more often a husband with other sexual partners than Filipino women. Herpes simplex virus type 2 was independently associated with younger age at first intercourse in both countries. More than one lifetime sexual partner, a husband with other sexual partners, urban/semi-urban residence, and no history of condom use were HSV-2 risk factors in Brazil, but not in the Philippines, where long-term hormonal contraceptive use was associated with increased risk. CONCLUSIONS: The higher HSV-2 seroprevalence in Brazil than in the Philippines may be explained largely by differences in the sexual behavior of women and their husbands. Herpes simplex virus type 2 seroprevalence data may be used as a marker of past sexual behavior for the direct comparison of different population groups.
Authors: Emily T Martin; Elizabeth Krantz; Sami L Gottlieb; Amalia S Magaret; Andria Langenberg; Lawrence Stanberry; Mary Kamb; Anna Wald Journal: Arch Intern Med Date: 2009-07-13
Authors: Gail F Shust; Sylvia Cho; Mimi Kim; Rebecca P Madan; Esmeralda M Guzman; Margaret Pollack; Julia Epstein; Hillel W Cohen; Marla J Keller; Betsy C Herold Journal: Am J Reprod Immunol Date: 2009-12-15 Impact factor: 3.886
Authors: A C Rodríguez; P E Castle; J S Smith; C Bratti; A Hildesheim; M Schiffman; R Viscidi; R D Burk; R L Ashley; X Castellsagué; R Herrero Journal: Sex Transm Infect Date: 2003-12 Impact factor: 3.519
Authors: Hoa Van Le; Victor J Schoenbach; Rolando Herrero; Anh Thi Hoang Pham; Hieu Trong Nguyen; Thuy Thi Nguyen; Nubia Muñoz; Silvia Franceschi; Salvatore Vaccarella; Max D Parkin; Peter J F Snijders; Rhoda Ashley Morrow; Jennifer S Smith Journal: Sex Transm Dis Date: 2009-10 Impact factor: 2.830
Authors: Junia Rodrigues; Beatriz Grinsztejn; Francisco I Bastos; Luciane Velasque; Paula M Luz; Claudia T V de Souza; Ingebourg Georg; Jose H Pilotto; Valdilea G Veloso Journal: BMC Infect Dis Date: 2009-04-01 Impact factor: 3.090
Authors: Evan S Vista; Michael H Weisman; Mariko L Ishimori; Hua Chen; Rebecka L Bourn; Ben F Bruner; Laniyati Hamijoyo; Robelle D Tanangunan; Noga J Gal; Julie M Robertson; John B Harley; Joel M Guthridge; Sandra V Navarra; Judith A James Journal: Lupus Sci Med Date: 2017-07-28
Authors: J M Warnecke; M Pollmann; V Borchardt-Lohölter; A Moreira-Soto; S Kaya; A G Sener; E Gómez-Guzmán; L Figueroa-Hernández; W Li; F Li; K Buska; K Zakaszewska; K Ziolkowska; J Janz; A Ott; T Scheper; W Meyer Journal: Epidemiol Infect Date: 2020-10-30 Impact factor: 2.451